Ocrelizumab 300mg/10ml solution for infusion vials

SNOMED code
35058211000001100
Active compound
Ocrelizumab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
10 ml, vial
Ingredients
Ocrelizumab — 30 mg / 1 ml based on ingredient substance
Form & Route
solutioninfusion.intravenous
Solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd)

in short Ocrevus 300mg/10ml concentrate for inf vials

Ocrevus 300mg/10ml concentrate for solution for infusion vials

SNOMED code
35424111000001107
Supplier
Roche Products Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial
35424211000001101   ref. pack		💯 Available

Legal category: POM		5000471007466

End: 7613326019941
NHS Indicative Price
£4,790		• Hospital
  • • Prescription Charges
 —
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd)

in short Ocrevus 300mg/10ml concentrate for inf vials

Ocrevus 300mg/10ml concentrate for solution for infusion vials

SNOMED code
35058311000001108
Status
❌ Invalid
Supplier
Roche Products Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Ocrevus 300mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) 1 vial
35058511000001102   ref. pack		 ❌ Invalid
💯 Available

Legal category: POM		No Price Available
—
  • • Prescription Charges
 —

Reference packs

Ocrelizumab 300mg/10ml solution for infusion vials 1 vial
SNOMED code
35058411000001101
Quantity and unit
1 vial
Packs